NexImmune, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in NexImmune, Inc..
Log in to see more information.

News

What Is Going on With NexImmune (NEXI) Stock Today?
What Is Going on With NexImmune (NEXI) Stock Today?

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nEmbattled biotech firm NexImmune is attempting to make the best out of a terrible situation, thus boosting NEXI stock.\nThe post What Is...\n more…

PNC Financial Services Group Inc. Sells 303,399 Shares of NexImmune, Inc. (NASDAQ:NEXI)
PNC Financial Services Group Inc. Sells 303,399 Shares of NexImmune, Inc. (NASDAQ:NEXI)

Ticker Report PNC Financial Services Group Inc. cut its holdings in NexImmune, Inc. (NASDAQ:NEXI - Free Report) by 96.0% in the 4th quarter, according to the company in its most recent filing with the Securities...\n more…

NEXI Stock Earnings: NexImmune Reported Results for Q1 2024
NEXI Stock Earnings: NexImmune Reported Results for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNexImmune just reported results for the first quarter of 2024.\nThe post NEXI Stock Earnings: NexImmune Reported Results for Q1 2024...\n more…

NEXI Stock Earnings: NexImmune Reported Results for Q4 2023
NEXI Stock Earnings: NexImmune Reported Results for Q4 2023

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNexImmune just reported results for the fourth quarter of 2023.\nThe post NEXI Stock Earnings: NexImmune Reported Results for Q4 2023...\n more…

Short Interest in NexImmune, Inc. (NASDAQ:NEXI) Decreases By 49.4%
Short Interest in NexImmune, Inc. (NASDAQ:NEXI) Decreases By 49.4%

Zolmax NexImmune, Inc. (NASDAQ:NEXI - Get Free Report) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 17,800 shares, a drop of 49.4% from the March...\n more…

NexImmune slips after securities offering
NexImmune slips after securities offering

Seeking Alpha - Healthcare NexImmune slips after securities offering...\n more…